NCT00345345 2022-05-03
Alemtuzumab (Campath) to Treat T-Large Granular Lymphocyte Leukemia
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Children's Oncology Group
Children's Hospital of Philadelphia
Merck Sharp & Dohme LLC
National Hematological Society, Russia
Janssen Korea, Ltd., Korea